Nishiyama H, Yonese J, Kawahara T, Matsumoto R, et al. TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naive Locally Advanced or Metastatic Urothelial Carcinoma. Mol Cancer Ther 2024;23:532-540.
PMID: 38060587